Ultrasound-Guided Thyroid FNA Biopsy

What is a thyroid FNA biopsy?

Fine-needle aspiration, commonly called FNA or FNAB, is a procedure that removes a small sample of cells from a thyroid nodule. Ultrasound is usually used to guide the needle into the intended area.

The sample is examined under a microscope. FNA does not remove the nodule and does not by itself treat it.

When might FNA be recommended?

The decision depends on the nodule's ultrasound appearance and size, thyroid blood tests, symptoms, medical history, and other risk factors. Some nodules can be monitored without biopsy.

How should patients prepare?

• Tell the clinical team about all medicines and supplements, especially anticoagulants or antiplatelet medicines.
• Do not stop a prescribed medicine unless the prescribing or procedural clinician gives specific instructions.
• Ask whether eating and drinking are permitted. Fasting is often unnecessary when sedation is not planned, but facility instructions vary.
• Wear comfortable clothing and remove necklaces or other items around the neck.
• Report allergies, bleeding problems, pregnancy, or any previous difficulty with procedures.

What happens during the biopsy?

The patient usually lies on the back with the neck gently extended. The skin is cleaned, and a local or topical anesthetic may be used. The clinician watches the needle on ultrasound while collecting cells from selected parts of the nodule.

More than one sample may be needed. Patients are commonly asked to remain still and avoid talking, coughing, or swallowing while the needle is in place. Pressure is applied to the biopsy site afterward.

What happens after FNA?

Mild soreness or bruising can occur. The facility should provide instructions about activity, discomfort, medicines, and when to seek help.

Contact the clinical team promptly for expanding neck swelling, persistent bleeding, trouble breathing or swallowing, fever, or worsening pain. Emergency symptoms require urgent care.

How are the results reported?

Many laboratories use the Bethesda System, which places thyroid FNA findings into six diagnostic categories. Results may be benign, malignant, suspicious for malignancy, atypia of undetermined significance, follicular neoplasm or suspicious for follicular neoplasm, or nondiagnostic.

The recommended next step depends on the category and the full clinical picture. It may include ultrasound monitoring, repeat FNA, molecular testing, surgery, or another evaluation. Ask when and how results will be communicated because timing varies.

What are the limitations and risks?

FNA is generally well tolerated, but no test is perfect. A sample may not contain enough cells, and a benign result does not eliminate the need for follow-up when ultrasound or clinical findings remain concerning.

Possible complications include pain, bruising, bleeding, infection, or temporary voice symptoms. Serious complications are uncommon. Individual risk may be different for patients with bleeding disorders or medicines that affect clotting.

Questions to ask the clinical team

• Why does this nodule need biopsy?
• Which ultrasound findings influenced the recommendation?
• Should I change any medicines before the procedure?
• Will local anesthetic be used?
• How many samples may be collected?
• How and when will I receive the result?
• What follow-up is needed for each possible result?